accepted and acknowledged
on 13 Sep 2024
Last Applicant/ Owned by
Teslova 3
Plzen
CZ
30100
Serial Number
86970800 filed on 11th Apr 2016
Registration Number
5283583 registered on 12th Sep 2017
Correspondent Address
Karen L. Elbing
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Scientific and technological services and research projects for the preparation of peptide and antibody libraries, and for the identification and characterisation of binding molecules, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects for the preparation, identification and characterisati Read More
Scientific and technological services and research projects for the preparation of peptide and antibody libraries, and for the identification and characterisation of binding molecules, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects for the preparation, identification and characterisation of peptides or antibodies, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects for the preparation, identification and characterisation of recombinant antibodies, single-chain antibodies, diabodies, tandabs, flexibodies, triabodies, tetrabodies, bivalent antibodies, multivalent antibodies, whole immunoglobulins, or antibody fragments, in particular Fab and scFv fragments, and of nucleic acid sequences coding for these molecules, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to batch-cloning and screening of natural, engineered and immunized libraries, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to batch-cloning and screening of antibody libraries, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to antibody development strategies, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to the optimization, maturation and humanization of antibody drug candidates, namely scientific research and analysis in the field of antibody research and drug design; scientific and technological services and research projects in relation to multi-factor antibody optimization, namely scientific research and analysis in the field of antibody research and drug design; scientific and technological services and research projects in relation to the optimization of antibody binding affinity, antibody stability, species cross-reactivity, specificity, developability, producibility, and human properties, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to human and nonhuman lead antibody technology, namely scientific research and analysis in the field of antibody research and antibody optimization
N/A
N/A
No 86970800
No Service Mark
No 50125-T83001
Yes
No
No
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
13th Sep 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
13th Sep 2024 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
13th Sep 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
06th Mar 2024 | TEAS SECTION 8 & 15 RECEIVED |
12th Sep 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
12th Sep 2017 | REGISTERED-PRINCIPAL REGISTER |
27th Jun 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
27th Jun 2017 | PUBLISHED FOR OPPOSITION |
07th Jun 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
04th May 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |